Bath & Body Works, Inc. has received a consensus Moderate Buy rating from analysts. The company has demonstrated long-term earnings potential and analysts believe the stock could see an increase. It has recently announced an Annual Candle Day deal and has seen a surge in its stock by 5.0%. The company has maintained a $0.20 dividend and has shown resilience in the global retail market. Their shares have bounced back 31% although the business performance was reported to be trailing the market. The stock had a significant jump post guidance boost and saw a decrease in short interest.
BBWI has topped Q3 earnings and revenue estimates and recruited over 30,000 new seasonal associates for holiday season. Notably, there are reasons for fall in its stock, including negative feedback from Q2 sales that missed targets and a perceived lack of innovation due to the departure of President, Retail Julie Rosen. Q3 sales growth has been impressive, alongside a raise in full-year outlook, despite a lesser earnings growth rate. There's also speculation about stock resilience amid retail challenges.
Bath Body Works BBWI News Analytics from Thu, 23 May 2024 07:00:00 GMT to Thu, 19 Dec 2024 07:38:07 GMT - Rating 7 - Innovation -3 - Information 9 - Rumor -4
